Physicians say they are distressed about the short- and long-term health effects stemming from missed and delayed cancer screenings and diagnoses due to disruption from the COVID-19 pandemic, the Wall Street Journal reports.
Oncology
Wellesley, Mass.-based Harvard Pilgrim Health Care formed a new partnership with Oncology Analytics to help manage cancer patients' clinical and claims data, according to an Oct. 13 news release.
Women who were diagnosed with cancer as adolescents or young adults can be especially vulnerable to disruptions in their employment, according to findings published in Cancer, the peer-reviewed journal of the American Cancer Society.
Indiana University School of Medicine has named Kelvin Lee, MD, director of the IU Melvin and Bren Simon Comprehensive Cancer Center.
Nashville, Tenn.-based Vanderbilt-Ingram Cancer Center will provide hematology-oncology services for Chattanooga, Tenn.-based Erlanger Health System.
Advertisement
James K. McCloskey II, MD, has been named permanent chief of the division of leukemia at Hackensack Meridian Health's John Theurer Cancer Center, the center said Oct. 7.
The following hospitals, health systems and cancer treatment centers have opened cancer care facilities or announced plans for them in the last month.
City of Hope, a Duarte, Calif.-based cancer research and treatment center, invested $40 million to create a subsidiary that helps employers provide cancer information and expert opinions to their employees.
Seattle-based Fred Hutchinson Cancer Research Center opened a COVID-19 research facility Oct. 5.
Penn State Cancer Institute in Hershey, Pa., named Mitchell Machtay, MD, associate director for clinical research.